SCHEMBL1153566

SCHEMBL1153566

COc1nccc(C=NO)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
ALOX15 P16050 1/20 0.46
HSP90AA1 P07900 1/20 0.44
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GFER P55789 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.37
MAPK1 P28482 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.35
PDPK1 O15530 1/20 0.35
PLAU P00749 1/20 0.33
CCR1 P32246 1/20 0.33
CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1153563 1.00 KDM4E (0.46) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL3406360 0.92 KDM4E (0.41) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL3404211 0.87 L3MBTL1 (0.38) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL2752613 0.76 GRM4 (0.49) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL2752612 0.76 GRM4 (0.49) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL4976296 0.76 ALDH1A1 (0.39) KDM4ENPSR1RAB9AKMT2AMAPK1
SCHEMBL28313608 0.75 KDM4E (0.58) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL13698746 0.73 L3MBTL1 (0.45) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL17113388 0.73 L3MBTL1 (0.45) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1
SCHEMBL31610007 0.73 L3MBTL1 (0.45) KDM4EL3MBTL1ALOX15HSP90AA1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039693-A1 Pyrimidylmethyl Sulfonamide Compounds BASF SE (DE) 2011-02-17 US disclosed
WO-2009101079-A1 PYRIMIDYLMETHYL SULFONAMIDE COMPOUNDS BASF SE (DE) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039693-A1 Pyrimidylmethyl Sulfonamide Compounds TPMT, NQO2, TST KDM4E 1251/4885L3MBTL1 4714/4885ALOX15 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.